As a key player in the immune response, IFN is also involved in lipid metabolism and the development of atherosclerosis, inducing oxidative stress, promoting foam cell accumulation, enhancing platelet-derived growth factor expression and destabilising plaques make the IFN and STAT/JAK pathway a promising target for atherosclerosis treatment. The gene discussed is SOAT1; the disease is atherosclerosis.